Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 71.46% vs 236.41% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 6.17% vs 30.95% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "231.30",
          "val2": "134.90",
          "chgp": "71.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-217.70",
          "val2": "-197.40",
          "chgp": "-10.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "6.40",
          "val2": "6.00",
          "chgp": "6.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.30",
          "val2": "3.60",
          "chgp": "102.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-203.90",
          "val2": "-217.30",
          "chgp": "6.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-941.30%",
          "val2": "-1,605.50%",
          "chgp": "66.42%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 295.27% vs 0.00% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 15.17% vs -50.50% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "359.30",
          "val2": "90.90",
          "chgp": "295.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-896.80",
          "val2": "-1,083.60",
          "chgp": "17.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "22.80",
          "val2": "7.60",
          "chgp": "200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "14.50",
          "val2": "22.50",
          "chgp": "-35.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-939.70",
          "val2": "-1,107.70",
          "chgp": "15.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,710.00%",
          "val2": "-12,718.70%",
          "chgp": "1,000.87%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

231.30

134.90

71.46%

Operating Profit (PBDIT) excl Other Income

-217.70

-197.40

-10.28%

Interest

6.40

6.00

6.67%

Exceptional Items

7.30

3.60

102.78%

Consolidate Net Profit

-203.90

-217.30

6.17%

Operating Profit Margin (Excl OI)

-941.30%

-1,605.50%

66.42%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 71.46% vs 236.41% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 6.17% vs 30.95% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

359.30

90.90

295.27%

Operating Profit (PBDIT) excl Other Income

-896.80

-1,083.60

17.24%

Interest

22.80

7.60

200.00%

Exceptional Items

14.50

22.50

-35.56%

Consolidate Net Profit

-939.70

-1,107.70

15.17%

Operating Profit Margin (Excl OI)

-2,710.00%

-12,718.70%

1,000.87%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 295.27% vs 0.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 15.17% vs -50.50% in Dec 2023

All Annual Results